Institute of Clinical Neurosciences (ICN)

Organization profile

Organisation profile

The Institute of Clinical Neurosciences (ICN) is a confederation of scientists and clinicians largely now based at Southmead Hospital, dedicated to translational neuroscience. Our projects and programmes turn laboratory-based experiments in cellular and molecular biology into new treatments for patients and have built us a world wide reputation for outstanding research especially in the fields of dementia, Parkinson's disease, and multiple sclerosis and stem cells.

Much of our clinically centred research occurs in the new ICN Brain Centre at Southmead, a facility opened jointly by the Vice Chancellor Professor Hugh Brady and the Chief Executive of North Bristol NHS Trust, Andria Young, in late 2015. 

International recognition for clinical neuroscience at Bristol is founded on the major role North Bristol in particular has played in the history of specialist care for brain disorders - first at the Burden Institute, and later at Frenchay Hospital. The ICN was established in 1999 to bring together clinical neuroscience groups and consolidate a world class reputation for Bristol Neuroscience.

Fingerprint Dive into the research topics where Institute of Clinical Neurosciences (ICN) is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.

  • Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Profiles

    No photo of Philip L Clatworthy

    Dr Philip L Clatworthy

    Person: Group lead, Honorary and Visiting Academic

    20032019

    Research Output

  • A Neurologist's Guide to REM Sleep Behaviour Disorder

    Roguski, A., Rayment, D., Whone, A., Jones, M. & Rolinski, M., 25 May 2020, (Accepted/In press) In : Frontiers in Neurology. 32 p.

    Research output: Contribution to journalReview article (Academic Journal)

  • A Rapid Robust Method for Subgrouping Non-NF2 Meningiomas According to Genotype and Detection of Lower Levels of M2 Macrophages in AKT1 E17K Mutated Tumours

    Adams, C. L., Ercolano, E., Ferluga, S., Sofela, A., Dave, F., Negroni, C., Kurian, K. M., Hilton, D. A. & Hanemann, C. O., 13 Feb 2020, In : International Journal of Molecular Sciences. 21, 4

    Research output: Contribution to journalArticle (Academic Journal)

  • Projects

    Student theses

    A preclinical and clinical investigation into quantitative magnetic resonance imaging as a tool for estimating onset time in hyperacute ischaemic stroke

    Author: McGarry, B., 12 May 2020

    Supervisor: Kauppinen, R. (Supervisor) & Gilchrist, I. (Supervisor)

    Student thesis: Doctoral ThesisDoctor of Philosophy (PhD)

    File

    Towards Measures for Translation : An Exploration of Neurophysiological Biomarkers of Disability in Multiple Sclerosis

    Author: Canham, L. J. W., 7 May 2019

    Supervisor: Cottrell, D. A. (Supervisor) & Whone, A. L. (Supervisor)

    Student thesis: Doctoral ThesisDoctor of Philosophy (PhD)

    File

    Activities

    • 2 Participation in conference
    • 1 Editorial activity

    X Northern Lights Neuroscience Symposium

    Claire M Rice (Participant)

    24 May 2013

    Activity: Participating in or organising an event typesParticipation in conference

    British Neuropathological Society 2013

    Claire M Rice (Participant)

    15 Mar 2013

    Activity: Participating in or organising an event typesParticipation in conference

    BMJ (Journal)

    Neil J Scolding (Editor)

    2010

    Activity: Publication peer-review and editorial work typesEditorial activity